심혈관 의료기기 시장(2026-2030년)

The global cardiovascular medical devices market is forecasted to grow by USD 24314.7 mn during 2025-2030, accelerating at a CAGR of 7.9% during the forecast period. The report on the global cardiovascular medical devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing adoption of minimally invasive and transcatheter procedures, technological advancements and digital health integration, rising global burden of cardiovascular disease and demographic transitions.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global cardiovascular medical devices market is segmented as below:

By Product

• Diagnostic systems
• Surgical devices

By Disease Type

• Coronary artery disease
• Arrhythmia
• Heart failure
• Structural heart disease
• Others

By End-User

• Hospitals
• ASCs
• Specialty clinics
• Home healthcare settings
• Rehabilitation centers

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the proliferation of value based procurement and outcome focused reimbursement models as one of the prime reasons driving the global cardiovascular medical devices market growth during the next few years. Also, advancements in bioresorbable materials and next generation biocompatible coatings and strategic expansion into specialized ambulatory surgery centers and outpatient settings will lead to sizable demand in the market.

The report on the global cardiovascular medical devices market covers the following areas:

• Global cardiovascular medical devices market sizing
• Global cardiovascular medical devices market forecast
• Global cardiovascular medical devices market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global cardiovascular medical devices market vendors that include Argon Medical Devices Inc., B.Braun SE, Boston Scientific Corp., Canon Inc., Cardinal Health Inc., Cook Group Inc., Edwards Lifesciences Corp., Eurocor Tech GmbH, GE HealthCare Technologies, Getinge AB, Johnson and Johnson Services, Lepu Medical Co. Ltd., LivaNova PLC, Medtronic Plc, Merit Medical Systems Inc., Newtech Medical Devices, Siemens AG, Teleflex Inc., Terumo Corp., W. L. Gore and Associates. Also, the global cardiovascular medical devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Disease Type
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Cardiovascular Medical Devices Market 2020 - 2024
  • Historic Market Size - Data Table on Global Cardiovascular Medical Devices Market 2020 - 2024 ($ million)
• 5.2 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.3 Disease Type segment analysis 2020 - 2024
  • Historic Market Size - Disease Type Segment 2020 - 2024 ($ million)
• 5.4 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global cardiovascular medical devices market
• 6.2 Impact of geopolitical conflicts on global cardiovascular medical devices market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Product

• 8.1 Market segments
• 8.2 Comparison by Product
• 8.3 Diagnostic systems - Market size and forecast 2025-2030
• 8.4 Surgical devices - Market size and forecast 2025-2030
• 8.5 Market opportunity by Product
  • Market opportunity by Product ($ million)

9 Market Segmentation by Disease Type

• 9.1 Market segments
• 9.2 Comparison by Disease Type
• 9.3 Coronary artery disease - Market size and forecast 2025-2030
• 9.4 Arrhythmia - Market size and forecast 2025-2030
• 9.5 Heart failure - Market size and forecast 2025-2030
• 9.6 Structural heart disease - Market size and forecast 2025-2030
• 9.7 Others - Market size and forecast 2025-2030
• 9.8 Market opportunity by Disease Type
  • Market opportunity by Disease Type ($ million)

10 Market Segmentation by End-user

• 10.1 Market segments
• 10.2 Comparison by End-user
• 10.3 Hospitals - Market size and forecast 2025-2030
• 10.4 ASCs - Market size and forecast 2025-2030
• 10.5 Specialty clinics - Market size and forecast 2025-2030
• 10.6 Home healthcare settings - Market size and forecast 2025-2030
• 10.7 Rehabilitation centers - Market size and forecast 2025-2030
• 10.8 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Thailand - Market size and forecast 2025-2030
  • 12.5.6 Indonesia - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 Colombia - Market size and forecast 2025-2030
  • 12.6.7 South Africa - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Increasing adoption of minimally invasive and transcatheter procedures
  • Technological advancements and digital health integration
  • Rising global burden of cardiovascular disease and demographic transitions
• 13.2 Market challenges
  • Stringent regulatory frameworks and prolonged clinical approval cycles
  • Economic pressures and price sensitivity in healthcare procurement. Significant
  • Technical complexity and shortage of specialized clinical expertise
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Proliferation of value based procurement and outcome focused reimbursement models
  • Advancements in bioresorbable materials and next generation biocompatible coatings
  • Strategic expansion into specialized ambulatory surgery centers and outpatient settings

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Argon Medical Devices Inc.
  • Argon Medical Devices Inc. - Overview
  • Argon Medical Devices Inc. - Product / Service
  • Argon Medical Devices Inc. - Key offerings
  • SWOT
• 15.5 B.Braun SE
  • B.Braun SE - Overview
  • B.Braun SE - Product / Service
  • B.Braun SE - Key offerings
  • SWOT
• 15.6 Boston Scientific Corp.
  • Boston Scientific Corp. - Overview
  • Boston Scientific Corp. - Business segments
  • Boston Scientific Corp. - Key news
  • Boston Scientific Corp. - Key offerings
  • Boston Scientific Corp. - Segment focus
  • SWOT
• 15.7 Canon Inc.
  • Canon Inc. - Overview
  • Canon Inc. - Business segments
  • Canon Inc. - Key offerings
  • Canon Inc. - Segment focus
  • SWOT
• 15.8 Cardinal Health Inc.
  • Cardinal Health Inc. - Overview
  • Cardinal Health Inc. - Business segments
  • Cardinal Health Inc. - Key offerings
  • Cardinal Health Inc. - Segment focus
  • SWOT
• 15.9 Cook Group Inc.
  • Cook Group Inc. - Overview
  • Cook Group Inc. - Product / Service
  • Cook Group Inc. - Key offerings
  • SWOT
• 15.10 Edwards Lifesciences Corp.
  • Edwards Lifesciences Corp. - Overview
  • Edwards Lifesciences Corp. - Business segments
  • Edwards Lifesciences Corp. - Key offerings
  • Edwards Lifesciences Corp. - Segment focus
  • SWOT
• 15.11 GE HealthCare Technologies
  • GE HealthCare Technologies - Overview
  • GE HealthCare Technologies - Business segments
  • GE HealthCare Technologies - Key news
  • GE HealthCare Technologies - Key offerings
  • GE HealthCare Technologies - Segment focus
  • SWOT
• 15.12 Getinge AB
  • Getinge AB - Overview
  • Getinge AB - Business segments
  • Getinge AB - Key offerings
  • Getinge AB - Segment focus
  • SWOT
• 15.13 Johnson and Johnson Services
  • Johnson and Johnson Services - Overview
  • Johnson and Johnson Services - Business segments
  • Johnson and Johnson Services - Key news
  • Johnson and Johnson Services - Key offerings
  • Johnson and Johnson Services - Segment focus
  • SWOT
• 15.14 Medtronic Plc
  • Medtronic Plc - Overview
  • Medtronic Plc - Business segments
  • Medtronic Plc - Key news
  • Medtronic Plc - Key offerings
  • Medtronic Plc - Segment focus
  • SWOT
• 15.15 Siemens AG
  • Siemens AG - Overview
  • Siemens AG - Business segments
  • Siemens AG - Key news
  • Siemens AG - Key offerings
  • Siemens AG - Segment focus
  • SWOT
• 15.16 Teleflex Inc.
  • Teleflex Inc. - Overview
  • Teleflex Inc. - Business segments
  • Teleflex Inc. - Key news
  • Teleflex Inc. - Key offerings
  • Teleflex Inc. - Segment focus
  • SWOT
• 15.17 Terumo Corp.
  • Terumo Corp. - Overview
  • Terumo Corp. - Business segments
  • Terumo Corp. - Key news
  • Terumo Corp. - Key offerings
  • Terumo Corp. - Segment focus
  • SWOT
• 15.18 W. L. Gore and Associates
  • W. L. Gore and Associates - Overview
  • W. L. Gore and Associates - Product / Service
  • W. L. Gore and Associates - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations